Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Bouffet

Showing results (241-250 of 532) with videos related to

Pageof 54
Sort By:
Neuroimage. Clinical|June 30, 2019
Facial emotion recognition in children treated for posterior fossa tumours and typically developing children: A divergence of predictorsIska Moxon-Emre, Norman A S Farb, Adeoye A Oyefiade, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 2, 2013
Attitudes of Canadian researchers toward the return to participants of incidental and targeted genomic findings obtained in a pediatric research settingConrad V Fernandez, Caron Strahlendorf, Denise Avard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 14, 2022
Efficacy and Safety of Trametinib Monotherapy or in Combination With Dabrafenib in Pediatric <i>BRAF</i> V600-Mutant Low-Grade GliomaEric Bouffet, Birgit Geoerger, Christopher Moertel, et al.
JCO Global Oncology|January 17, 2025
Frequency and Impact of Constitutional Mismatch Repair Deficiency in Patients With High-Grade Glioma, a Retrospective Analysis of 7 Years in Pakistan: an IRRDC StudyNaureen Mushtaq, Khurram Minhas, Farrah Bashir, et al.
Journal of Pediatric Hematology/Oncology|May 25, 2010
Atypical teratoid or rhabdoid tumors: improved outcome with high-dose chemotherapyTal Finkelstein-Shechter, Adam Gassas, Donald Mabbott, et al.
Journal of Neuro-Oncology|June 12, 2016
Single-agent erlotinib versus oral etoposide in patients with recurrent or refractory pediatric ependymoma: a randomized open-label studyRegina I Jakacki, Margaret A Foley, Julie Horan, et al.
Developmental Science|May 23, 2023
Network connectivity underlying episodic memory in children: Application of a pediatric brain tumor survivor injury modelKatie Wade Alonso, Noor Z Al Dahhan, Lily Riggs, et al.
Neuroimage. Clinical|June 8, 2018
Repairing the brain with physical exercise: Cortical thickness and brain volume increases in long-term pediatric brain tumor survivors in response to a structured exercise interventionKamila U Szulc-Lerch, Brian W Timmons, Eric Bouffet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 12, 2014
Impact of craniospinal dose, boost volume, and neurologic complications on intellectual outcome in patients with medulloblastomaIska Moxon-Emre, Eric Bouffet, Michael D Taylor, et al.
Neuro-Oncology Practice|December 29, 2025
Dabrafenib in pediatric patients with <i>BRAF</i> V600 mutation-positive high-grade glioma: Results from a phase 1/2a single-arm studyBirgit Geoerger, Lucas Moreno, Eric Bouffet, et al.
Pageof 54

Showing results (241-250 of 532) with videos related to

Sort By:
Pageof 54
Neuroimage. Clinical|June 30, 2019
Facial emotion recognition in children treated for posterior fossa tumours and typically developing children: A divergence of predictorsIska Moxon-Emre, Norman A S Farb, Adeoye A Oyefiade, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 2, 2013
Attitudes of Canadian researchers toward the return to participants of incidental and targeted genomic findings obtained in a pediatric research settingConrad V Fernandez, Caron Strahlendorf, Denise Avard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 14, 2022
Efficacy and Safety of Trametinib Monotherapy or in Combination With Dabrafenib in Pediatric <i>BRAF</i> V600-Mutant Low-Grade GliomaEric Bouffet, Birgit Geoerger, Christopher Moertel, et al.
JCO Global Oncology|January 17, 2025
Frequency and Impact of Constitutional Mismatch Repair Deficiency in Patients With High-Grade Glioma, a Retrospective Analysis of 7 Years in Pakistan: an IRRDC StudyNaureen Mushtaq, Khurram Minhas, Farrah Bashir, et al.
Journal of Pediatric Hematology/Oncology|May 25, 2010
Atypical teratoid or rhabdoid tumors: improved outcome with high-dose chemotherapyTal Finkelstein-Shechter, Adam Gassas, Donald Mabbott, et al.
Journal of Neuro-Oncology|June 12, 2016
Single-agent erlotinib versus oral etoposide in patients with recurrent or refractory pediatric ependymoma: a randomized open-label studyRegina I Jakacki, Margaret A Foley, Julie Horan, et al.
Developmental Science|May 23, 2023
Network connectivity underlying episodic memory in children: Application of a pediatric brain tumor survivor injury modelKatie Wade Alonso, Noor Z Al Dahhan, Lily Riggs, et al.
Neuroimage. Clinical|June 8, 2018
Repairing the brain with physical exercise: Cortical thickness and brain volume increases in long-term pediatric brain tumor survivors in response to a structured exercise interventionKamila U Szulc-Lerch, Brian W Timmons, Eric Bouffet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 12, 2014
Impact of craniospinal dose, boost volume, and neurologic complications on intellectual outcome in patients with medulloblastomaIska Moxon-Emre, Eric Bouffet, Michael D Taylor, et al.
Neuro-Oncology Practice|December 29, 2025
Dabrafenib in pediatric patients with <i>BRAF</i> V600 mutation-positive high-grade glioma: Results from a phase 1/2a single-arm studyBirgit Geoerger, Lucas Moreno, Eric Bouffet, et al.
Pageof 54